Pharmaceutical Commerce - September/October 2014

Pharmaceutical Commerce sat down with Mr. Mortazavi recently; here's what he had to say.

Absence of agreed-on FDA guidance keeps biosimilars off the US market even as their use grows abroad

Battlefield over drug pricing

Blackstone Group-owned CDMO nets over $800 million

After patent expires, 'The industry has turned a corner'

Siren Interactive hires more executives, moves to downtown Chicago

The Drug Supply Chain Security Act creates uncertainty about which trading partners have responsibility for product verification

Modern training technologies make the prospect of days-long training courses an obsolete practice

Real-world data sources can provide new dimensions to marketing plans

Latest ZS AccessMonitor asks, 'Who are physicians listening to?'

First to gain newly established program reviewing therapy management and chronic care

Outsourced contract-administration provider highlights growth in invoicing and financial stewardship burdens

Meanwhile, competitor CSafe Global broadens its containers' usability

Our annual compilation of key vendors and service providers in this vital component of pharmaceutical distribution, together with a preview of the IQPC Cold Chain Forum and more late-breaking news

The drive for lower costs, safer products

Securing your supply chain

True 'market access' should involve coordinated approaches to patients and their healthcare providers

MDM practices are moving far beyond compliance concerns